According to NanoString Technologies's latest financial reports the company's current revenue (TTM) is $0.16 B. In 2022 the company made a revenue of $0.12 B a decrease over the years 2021 revenue that were of $0.14 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.16 B | 27.67% |
2022 | $0.12 B | -12.28% |
2021 | $0.14 B | 23.67% |
2020 | $0.11 B | -6.57% |
2019 | $0.12 B | 17.65% |
2018 | $0.10 B | -7.11% |
2017 | $0.11 B | 32.85% |
2016 | $86.48 M | 38.01% |
2015 | $62.66 M | 31.67% |
2014 | $47.59 M | 51.56% |
2013 | $31.4 M | 36.7% |
2012 | $22.97 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 26,277.92% | ๐บ๐ธ USA |
Agilent Technologies A | $6.73 B | 4,045.30% | ๐บ๐ธ USA |
Illumina ILMN | $4.50 B | 2,672.15% | ๐บ๐ธ USA |
PerkinElmer
PKI | $3.35 B | 1,966.47% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | $0.20 B | 23.42% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $2.67 B | 1,544.13% | ๐บ๐ธ USA |